Pharma companies are under pressure to improve the quality and efficiency of their content. Learn how to select your first SCA use case.
By treating content as data, rather than documents, most of the problems inherent in monolithic documents are remedied.
To automate content development, pharmaceutical companies must move to structured content authoring.
In pharma, some digital marketing teams have embraced multi-channel publishing as a way to meet regulatory requirements.
Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.
Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.